The concept of a “serious” genetic condition is frequently used in clinical settings and policies to regulate the use of reproductive genomic technologies, yet it lacks clear definition and consistency in its application. This article highlights the need for a common understanding of “serious” in the context of prenatal testing and reproductive genetics. Key distinctions include tensions between clinical care and public health, the effects of labelling a condition as serious, and differing perceptions of quality of life. The authors propose four core dimensions and four procedural elements to guide the assessment of seriousness, aiming to improve decision-making consistency in both policy and practice.1
Read more here.
References
- Kleiderman, E., Boardman, F., Newson, A. J., Laberge, A., Knoppers, B. M., & Ravitsky, V. (2024). Unpacking the notion of “serious” genetic conditions: towards implementation in reproductive decision-making? European Journal of Human Genetics. https://doi.org/10.1038/s41431-024-01681-0
Disclaimers
- The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred
